The US regulatory approval process for nicotine pouches is experiencing slowdowns due to concerns about youth access and addiction potential in non-smokers. The delays reflect growing scrutiny of whether nicotine pouches represent a public health risk by creating new nicotine users rather than serving as a smoking cessation tool. The outcome will likely influence tobacco product regulation and market access timelines.
Straits Times·US·about 3 hours ago
Eli Lilly has obtained US regulatory approval for Foundayo, an oral formulation targeting obesity, intensifying competition with Novo Nordisk's existing pill-based obesity treatments. This approval expands the competitive landscape in the high-growth obesity pharmaceutical market. Market implications include potential pricing pressure and market share redistribution among major pharmaceutical players.
Financial Times·US·about 4 hours ago
KKR has announced a $3 billion offer to take Japanese chemical manufacturer Taiyo private, marking a significant PE acquisition in Japan's chemicals sector. The deal represents ongoing interest from major PE firms in consolidating Japanese mid-cap industrials. Success depends on regulatory approval and shareholder acceptance.
Nikkei Asia·JP·about 3 hours ago